World Pharma News Digest - 26.03.2008

Aurobindo Pharma expands in Europe
Aurobindo Pharma announced that it has recently concluded a strategic
deal, for acquisition of Intellectual Property & Marketing
Authorizations, with TAD Italy, a generic company registered in Italy.
This acquisition will give Aurobindo an access to more than 70 ready
to market products which will fast track Aurobindo's entry into the
Italian generic market.
Read more...
http://www.worldpharmanews.com/content/view/347/1/

New EU project to focus on membrane proteins with the aim of finding
new treatments
A new, EU-funded project will investigate membrane proteins with the
aim of finding new treatments for a range of diseases. Membrane
proteins are responsible for transporting chemicals and messages
between the inside and outside of cells, and they are vital for every
process in the human body. Defective membrane proteins have been
implicated in a range of human diseases, including diabetes, heart
disease, epilepsy, depression, osteoporosis, stomach ulcers and
cataracts.
Read more...
http://www.worldpharmanews.com/content/view/346/1/

GSK charitable support valued at £282 million in 2007
GlaxoSmithKline reported its 2007 global giving to charitable
initiatives totalled £282 million, equivalent to almost 4% of pre-tax
profits for the company (with the FTSE 100 average around 1%).
Donations of albendazole treatments for the company's flagship
programme to eliminate Lymphatic Filariasis (commonly known as
elephantiasis) were valued at £14 million, bringing the total number
of treatments given since GSK made its commitment 10 years ago to
almost 750 million.
Read more...
http://www.worldpharmanews.com/content/view/345/1/

Federal Court of Appeal in Canada Upholds Lipitor Enantiomer Patent
Pfizer Inc said today that the Federal Court of Appeal of Canada has
reversed a lower court ruling that held that Pfizer's enantiomer
patent could not block generic manufacturer Ranbaxy Laboratories
Limited from obtaining approval for a competitor product to Lipitor.
The appellate court issued an order prohibiting regulatory approval of
Ranbaxy's product in Canada until Pfizer's enantiomer (calcium salt)
patent - Canadian Patent No. 2,021,546 - expires in July 2010.
Read more...
http://www.worldpharmanews.com/content/view/344/1/

Zevalin(R) Receives Positive CHMP Opinion in Europe for First-Line
Consolidation Treatment
Bayer Schering Pharma AG has received a positive opinion from the
European Committee for Medicinal Products for Human Use (CHMP)
recommending Zevalin(R) ([90Y]-ibritumomab tiuxetan) as consolidation
therapy after remission induction in previously untreated patients
with follicular lymphoma (FL) in Europe.
Read more...
http://www.worldpharmanews.com/content/view/343/1/

Genzyme Withdraws Bioenvision's European Filing of Evoltra(R) in Elderly
AML Patients
Genzyme Corp. (Nasdaq: GENZ) announced the withdrawal of the European
application to extend the Evoltra(R) (clofarabine) product label to
include the treatment of elderly patients with acute myeloid leukemia
(AML). This application and the data on which it was based were filed
by Bioenvision, Ltd. before the company was acquired by Genzyme last
year.
Read more...
http://www.worldpharmanews.com/content/view/342/1/

Integrating sex and gender differences in health research
The EU-funded project GenderBasic has developed a number of
recommendations for the improved integration of sex and gender
differences in health-related research. Scientists must be aware of
these differences at all stages of their studies, from the research
content itself to the processes and methods employed in clinical
trials, says project coordinator, Dr Ineke Klinge of the University of
Maastricht in the Netherlands.
Read more...
http://www.worldpharmanews.com/content/view/341/1/

Middle East Healthcare Expansion Business Club Meetings
Fleming Gulf's Middle East Healthcare Expansion Business Club Meetings
(12th and 13h of May 2008, Dubai) will gather the upper-level decision
makers within the healthcare industry to discuss the hottest issues of
the day and obtain solutions for the latest development & expansion
programs. The event will provide an exclusive, business-driven
environment using prescheduled one-to-one business meetings and
educational sessions that are strictly limited to Medial directors and
Healthcare specialists.
Read more...
http://www.worldpharmanews.com/content/view/340/1/


World Pharma News .net / Published News:

New EU project to focus on membrane proteins with the aim of finding
new treatments
http://www.worldpharmanews.net/Research_Development/New_EU_project_to_focus_on_membrane_proteins_with_the_aim_of_finding_new_treatments/

Tres3D Medical Animation Studio - HOLOGRAPHIC MEDICAL MOA'S
http://www.worldpharmanews.net/Product/Tres3D_Medical_Animation_Studio_-_HOLOGRAPHIC_MEDICAL_MOAS/

Drug Injury Watch: Zyprexa And Diabetes: Is This A Tale Of Company
Greed Coupled With FDA Failure?
http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Zyprexa_And_Diabetes_Is_This_A_Tale_Of_Company_Greed_Coupled_With_FDA_Failure/

Pharmalot From Vytorin To Whytorin? The Enhance Saga
http://www.worldpharmanews.net/Blogs/Pharmalot_-_From_Vytorin_To_Whytorin_The_Enhance_Saga/

GSK charitable support valued at 282 million in 2007
http://www.worldpharmanews.net/Corporate/GSK_charitable_support_valued_at_%A3282_million_in_2007/

Vaccinations, Public Health and American Science Education
http://www.worldpharmanews.net/Blogs/Vaccinations_Public_Health_and_American_Science_Education-1/

Pharmalot Pfizer On The Hook For Off-Label Generic Use
http://www.worldpharmanews.net/Blogs/Pharmalot_-_Pfizer_On_The_Hook_For_Off-Label_Generic_Use/

Federal Court of Appeal in Canada Upholds Lipitor Enantiomer Patent
http://www.worldpharmanews.net/Product/Federal_Court_of_Appeal_in_Canada_Upholds_Lipitor_Enantiomer_Patent/

Zevalin Receives Positive CHMP Opinion in Europe for First-Line
Consolidation Treatment
http://www.worldpharmanews.net/Product/Zevalin%AE_Receives_Positive_CHMP_Opinion_in_Europe_for_First-Line_Consolidation_Treatment/

Genzyme Withdraws Bioenvision's European Filing of Evoltra in Elderly
AML Patients
http://www.worldpharmanews.net/Product/Genzyme_Withdraws_Bioenvisions_European_Filing_of_Evoltra%AE_in_Elderly_AML_Patients/
.

Relevant Pages

  • World Pharma News Digest - 26.03.2008
    ... Aurobindo Pharma expands in Europe ... aim of finding new treatments for a range of diseases. ... ZevalinReceives Positive CHMP Opinion in Europe for First-Line ... Fleming Gulf's Middle East Healthcare Expansion Business Club Meetings ...
    (sci.med.pharmacy)
  • Re: OT: Canada Posts Whopping 13.8 Billion Surplus
    ... Europe along with natural resources. ... the healthcare system even more than it is already. ... economy and healthcare if Hillary and her buddies got a hold of it. ... wouldn't have suffered the ravages of WWII and communism afterwards. ...
    (soc.men)
  • eHealthNews.EU Portal Digest
    ... Antwerp University Hospital works with IBM and I.R.I.S. ... The Antwerp University Hospital (UZA Belgium) has contracted IBM's ... spending on mobile health care in North America and Europe will reach ... The new HIMSS initiative is focused on bringing together healthcare IT ...
    (sci.med.informatics)
  • eHealthNews.EU Portal Digest
    ... Antwerp University Hospital works with IBM and I.R.I.S. ... The Antwerp University Hospital (UZA Belgium) has contracted IBM's ... spending on mobile health care in North America and Europe will reach ... The new HIMSS initiative is focused on bringing together healthcare IT ...
    (comp.protocols.dicom)